United Therapeutics | UTHR - Ebit



金融业
股票价格
USD 565.72
资产
USD 7.03B
现金及等价物
USD 1.19B
销售成本
USD 99.1M
流动资产
USD 2.88B
流动负债
USD 624.3M
债务
USD 200M
EBIT
USD 241.3M
EBITDA
USD 334.2M
员工
1.31K
EPS每股收益
USD 5.71
股本和储备
USD 6.28B
销售毛利
USD 733.4M
债务利息支出
USD 2.9M
利息收入
USD 31.5M
贷款资金
USD 100M
市值
USD 28.06B
净收入
USD 258.6M
营业费用
USD 6.28B
营业利润
USD 241.3M
普通股股本
USD 42.38M
PE价格收益
19.41
税前利润
USD 372.8M
销售收入
USD 832.5M
销售和管理费用
USD 184.1M
股票
USD 201.9M
贸易债权人
USD 520.2M
应收帐款人
USD 348.6M


Ebit 更改 日
Amarin USD -2.26M 564K 2025-12
Ardelyx USD -10.39M 20.29M 2026-06
Baxter International USD 314M 38M 2026-09
Bayer EUR 129M 626M 2026-09
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD 419.5M 663.3M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Gilead Sciences USD 3.85B 1.17B 2026-06
GlaxoSmithKline GBP 2.86B 251M 2026-09
Halozyme Therapeutics USD -63.72M 1.95M 2026-06
Insmed USD -81.83M 19.48M 2026-09
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
J&J USD 6.47B 1B 2026-09
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Moderna USD -815M 573M 2026-06
Omeros USD -48.15M 7.25M 2023-09
Pfizer USD 4.85B 5.03B 2026-09
PTC Therapeutics USD 146.03M 100.14M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Teva Pharmaceutical Industries USD 1.19B 954M 2026-09
United Therapeutics USD 241.3M 134.3M 2026-09
Vertex Pharmaceuticals USD 1.26B 11.3M 2026-09